Study Comparing SBS and LRTI for Treatment of CMC Arthritis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Study Comparing SBS and LRTI for Treatment of CMC Arthritis — Stella

Recruiting

Back to Arthritis trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

Canada

South Campus Research Unit for Bone and Soft Tissue, Calgary, Alberta

Fraser Orthopaedic Research Society, New Westminster, British Columbia

Key details

Sponsor

Fraser Orthopaedic Research Society

Enrollment target

~138 participants

Started

June 2022

Primary completion

February 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

50 Years and older

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov